Company Filing History:
2 out of 5 
1 out of 10 
1 out of 832,912 Years Active: 1997-2014
Title: Innovations of Stephen Patrick Mayalarp
Introduction
Stephen Patrick Mayalarp is a notable inventor based in Manchester, GB. He has made significant contributions to the field of chemistry, particularly in the development of anticancer compounds. With a total of four patents to his name, Mayalarp's work focuses on innovative chemical compounds and their applications in medicine.
Latest Patents
One of Mayalarp's latest patents is centered around substituted stilbenes and their reactions. This invention relates to stilbene and quinone compounds associated with combretastatin A-4, which are utilized as anticancer compounds and prodrugs. The compounds include those with an alkyl group on the double bond of cis- or trans-stilbenes, as well as compounds with multiple alkyl group substituents on the stilbene A ring. Additionally, the invention covers compounds with an alkoxy group at specific positions on the stilbene A ring and those that form BOC amino acid esters with the phenolic hydroxyl at the 3-position of the B ring. The patent also discusses the photochemical reactions of these stilbene compounds, including the release of active forms from prodrug conjugates and the isomerization of compounds, which can enhance their effectiveness in targeting tumors.
Career Highlights
Throughout his career, Stephen Patrick Mayalarp has worked with Salford Ultrafine Chemicals & Research Ltd. His innovative research has led to advancements in the field of anticancer treatments, showcasing his dedication to improving medical outcomes through chemistry.
Collaborations
Mayalarp has collaborated with notable individuals in his field, including Feodor Scheinmann and Keith William Lumbard. These partnerships have contributed to the development and refinement of his innovative ideas.
Conclusion
Stephen Patrick Mayalarp's contributions to the field of chemistry, particularly in the development of anticancer compounds, highlight his role as a significant inventor. His patents reflect a commitment to advancing medical science through innovative chemical research.